Observational studyAlimentary pharmacology & therapeutics2025

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.

Mathilde Osty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.